Matches in SemOpenAlex for { <https://semopenalex.org/work/W2569969069> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W2569969069 endingPage "386" @default.
- W2569969069 startingPage "386" @default.
- W2569969069 abstract "386 Background: Determination of the mutational status of key gene effectors along the EGFR signaling pathway plays a critical role in the management of metastatic colorectal cancer (mCRC) and other cancer types. We previously reported the rapid, multiplex, and sensitive detection of 7 common KRAS mutations in mCRC FFPE specimens using the Signature KRAS Mutations (RUO) kit. We show here that the same technology platform can be applied to the detection of additional clinically relevant mutations in the EGFR, BRAF, KRAS, NRAS and HRAS genes. Methods: Mutation panels were designed for multiplex PCR amplification of an internal control gene and discrete mutation regions in independent target genes. PCR products were hybridized on a liquid bead array carrying target-specific probes and sorted by flow cytometry using a Luminex 200 system. Genomic DNA was extracted from cell lines and representative flash frozen, FFPE or FNA clinical specimens using laboratory-validated extraction methods. Results: Using model plasmids and cell lines we developed specific assays for distinct mutations in KRAS codon 12/13, KRAS 3' UTR (rs61764370), BRAF codon 600/601, HRAS codon 12/61, NRAS codon 61, and EGFR exon 19/20/21. The various assays reached 0.1 to 5% analytical sensitivity and could be further combined in multiplex panels relevant to specific applications. The Signature KRAS/BRAF Mutations (RUO) kit, an assay for 12 KRAS mutations in codon 12/13 and BRAF V600E, was validated in over 250 mCRC FFPE specimens with >99% agreement with clinically validated methods. Specific detection of these 13 mutations and 6 HRAS/NRAS mutations was also demonstrated in thyroid nodule FNA specimens. Single-well detection of EGFR deletions in exon 19 together with the point mutations L858R and T790M was also successfully evaluated in lung specimens. Conclusions: The Signature technology platform is a specific, sensitive and flexible tool for the assessment of various mutations in different tissue types. The development and validation of broader mutation panels would likely facilitate the rapid molecular characterization of individual tumor specimens and the optimization of personalized treatments for mCRC and other cancer types. [Table: see text]" @default.
- W2569969069 created "2017-01-13" @default.
- W2569969069 creator A5006643830 @default.
- W2569969069 creator A5023336794 @default.
- W2569969069 creator A5032433308 @default.
- W2569969069 creator A5042225951 @default.
- W2569969069 creator A5046254597 @default.
- W2569969069 creator A5069050573 @default.
- W2569969069 creator A5072736112 @default.
- W2569969069 date "2011-02-01" @default.
- W2569969069 modified "2023-09-23" @default.
- W2569969069 title "A multiplex technology platform for the rapid detection of relevant mutations in the EGFR signaling pathway." @default.
- W2569969069 doi "https://doi.org/10.1200/jco.2011.29.4_suppl.386" @default.
- W2569969069 hasPublicationYear "2011" @default.
- W2569969069 type Work @default.
- W2569969069 sameAs 2569969069 @default.
- W2569969069 citedByCount "0" @default.
- W2569969069 crossrefType "journal-article" @default.
- W2569969069 hasAuthorship W2569969069A5006643830 @default.
- W2569969069 hasAuthorship W2569969069A5023336794 @default.
- W2569969069 hasAuthorship W2569969069A5032433308 @default.
- W2569969069 hasAuthorship W2569969069A5042225951 @default.
- W2569969069 hasAuthorship W2569969069A5046254597 @default.
- W2569969069 hasAuthorship W2569969069A5069050573 @default.
- W2569969069 hasAuthorship W2569969069A5072736112 @default.
- W2569969069 hasConcept C104317684 @default.
- W2569969069 hasConcept C1167327 @default.
- W2569969069 hasConcept C121608353 @default.
- W2569969069 hasConcept C153911025 @default.
- W2569969069 hasConcept C21790070 @default.
- W2569969069 hasConcept C2776470698 @default.
- W2569969069 hasConcept C2781187634 @default.
- W2569969069 hasConcept C2781188995 @default.
- W2569969069 hasConcept C501734568 @default.
- W2569969069 hasConcept C502942594 @default.
- W2569969069 hasConcept C526805850 @default.
- W2569969069 hasConcept C54355233 @default.
- W2569969069 hasConcept C86803240 @default.
- W2569969069 hasConceptScore W2569969069C104317684 @default.
- W2569969069 hasConceptScore W2569969069C1167327 @default.
- W2569969069 hasConceptScore W2569969069C121608353 @default.
- W2569969069 hasConceptScore W2569969069C153911025 @default.
- W2569969069 hasConceptScore W2569969069C21790070 @default.
- W2569969069 hasConceptScore W2569969069C2776470698 @default.
- W2569969069 hasConceptScore W2569969069C2781187634 @default.
- W2569969069 hasConceptScore W2569969069C2781188995 @default.
- W2569969069 hasConceptScore W2569969069C501734568 @default.
- W2569969069 hasConceptScore W2569969069C502942594 @default.
- W2569969069 hasConceptScore W2569969069C526805850 @default.
- W2569969069 hasConceptScore W2569969069C54355233 @default.
- W2569969069 hasConceptScore W2569969069C86803240 @default.
- W2569969069 hasIssue "4_suppl" @default.
- W2569969069 hasLocation W25699690691 @default.
- W2569969069 hasOpenAccess W2569969069 @default.
- W2569969069 hasPrimaryLocation W25699690691 @default.
- W2569969069 hasRelatedWork W1964070033 @default.
- W2569969069 hasRelatedWork W2029104788 @default.
- W2569969069 hasRelatedWork W2076946926 @default.
- W2569969069 hasRelatedWork W2102084976 @default.
- W2569969069 hasRelatedWork W2268032170 @default.
- W2569969069 hasRelatedWork W2569969069 @default.
- W2569969069 hasRelatedWork W2809385302 @default.
- W2569969069 hasRelatedWork W2955375133 @default.
- W2569969069 hasRelatedWork W2955562873 @default.
- W2569969069 hasRelatedWork W3083142796 @default.
- W2569969069 hasVolume "29" @default.
- W2569969069 isParatext "false" @default.
- W2569969069 isRetracted "false" @default.
- W2569969069 magId "2569969069" @default.
- W2569969069 workType "article" @default.